Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1983 1
2002 1
2003 3
2004 5
2007 2
2009 2
2010 3
2011 3
2012 6
2013 11
2014 8
2015 6
2016 4
2017 7
2018 5
2019 7
2020 2
2021 8
2022 10
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Prenatal genetic diagnosis of monogenic diseases.
Prior-de Castro C, Gómez-González C, Rodríguez-López R, Macher HC; Prenatal Diagnosis Commission and the Genetics Commission of the Spanish Society of Laboratory Medicine. Prior-de Castro C, et al. Among authors: rodriguez lopez r. Adv Lab Med. 2023 Mar 24;4(1):28-51. doi: 10.1515/almed-2023-0024. eCollection 2023 Apr. Adv Lab Med. 2023. PMID: 37359899 Free PMC article.
Network Viscoelasticity from Brillouin Spectroscopy.
Rodríguez-López R, Wang Z, Oda H, Erdi M, Kofinas P, Fytas G, Scarcelli G. Rodríguez-López R, et al. Biomacromolecules. 2024 Feb 12;25(2):955-963. doi: 10.1021/acs.biomac.3c01073. Epub 2023 Dec 29. Biomacromolecules. 2024. PMID: 38156622 Free PMC article.
Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications.
Perea-Romero I, Gordo G, Iancu IF, Del Pozo-Valero M, Almoguera B, Blanco-Kelly F, Carreño E, Jimenez-Rolando B, Lopez-Rodriguez R, Lorda-Sanchez I, Martin-Merida I, Pérez de Ayala L, Riveiro-Alvarez R, Rodriguez-Pinilla E, Tahsin-Swafiri S, Trujillo-Tiebas MJ; ESRETNET Study Group; ERDC Study Group; Associated Clinical Study Group; Garcia-Sandoval B, Minguez P, Avila-Fernandez A, Corton M, Ayuso C. Perea-Romero I, et al. Sci Rep. 2021 Jan 15;11(1):1526. doi: 10.1038/s41598-021-81093-y. Sci Rep. 2021. PMID: 33452396 Free PMC article.
Diversity of oncopharmacogenetic profile within Spanish population.
Ferrer Bolufer I, Galiana Vallés X, Izquierdo Álvarez S, Serrano Mira A, Guzmán Luján C, Safont Aguilera MJ, González Tarancón R, Bolaños Naranjo M, Carrasco Salas P, Santamaría González M, Rodríguez-López R. Ferrer Bolufer I, et al. Among authors: rodriguez lopez r. Pharmacogenet Genomics. 2024 Mar 18. doi: 10.1097/FPC.0000000000000530. Online ahead of print. Pharmacogenet Genomics. 2024. PMID: 38488402
84 results